相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis
Christian Hampp et al.
DIABETES CARE (2020)
A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial
Ahmad Haidar et al.
DIABETES CARE (2020)
Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial
Thomas F. Dejgaard et al.
DIABETES OBESITY & METABOLISM (2020)
Vascular and metabolic effects of metformin added to insulin therapy in patients with type 1 diabetes: A systematic review and meta-analysis
Ying-Shan Liu et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2020)
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes A Systematic Review and Network Meta-analysis
Apostolos Tsapas et al.
ANNALS OF INTERNAL MEDICINE (2020)
SGLT inhibitors in type 1 diabetes: weighing efficacy and side effects
Birgit Janssens et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2020)
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors
Thomas Danne et al.
DIABETES CARE (2019)
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018
Nicole C. Foster et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials
Haiyang Meng et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
Richard E. Pratley et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes
Veronique Gingras et al.
DIABETES OBESITY & METABOLISM (2018)
Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial
Tim Heise et al.
DIABETES OBESITY & METABOLISM (2017)
Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
Alanna Weisman et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial
Bo Ahren et al.
DIABETES CARE (2016)
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
Chantal Mathieu et al.
DIABETES CARE (2016)
Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide
Jennifer L. Sherr et al.
DIABETES CARE (2016)
Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus
Christian Seerup Frandsen et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes
Robert R. Henry et al.
DIABETES CARE (2015)
Efficacy and Safety of Metformin for Patients with Type 1 Diabetes Mellitus: A Meta-Analysis
Cong Liu et al.
Diabetes Technology & Therapeutics (2015)
Efficacy and safety of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a meta-analysis of randomized controlled trials for 1 to 2 years
Xiang-Yang Liu et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
David M. Nathan
DIABETES CARE (2014)
Incretins: Their physiology and application in the treatment of diabetes mellitus
Hale M. Tasyurek et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2014)
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
Kathleen M. Dungan et al.
LANCET (2014)
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
John B. Buse et al.
LANCET (2013)
Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes
Stuart A. Weinzimer et al.
DIABETES CARE (2012)
The use of metformin in type 1 diabetes: a systematic review of efficacy
S. Vella et al.
DIABETOLOGIA (2010)
The role of amylin in the physiology of glycemic control
W. A. Scherbaum
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial
RE Ratner et al.
DIABETIC MEDICINE (2004)
A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes
F Whitehouse et al.
DIABETES CARE (2002)
分享论文
